Archives of Disease in Childhood · 1985 · 90 citations · 6 references
PharmacyPediatricsPharmacotherapyCardiovascular PharmacotherapyPediatric Clinical PharmacologyPediatric PharmacotherapyCardiovascular DiseaseCoronary Artery DiseaseFamilial HypercholesterolemiaLipid-lowering TherapyPediatric Cardiac PharmacologyPediatric Preventive CardiologyBezafibrate TherapyPediatric Familial HypercholesterolemiaPlasma Cholesterol Levels
A six month, double blind, crossover controlled trial of bezafibrate was conducted in 14 children with familial hypercholesterolaemia all of whom had a strong family history of early coronary heart disease. The bezafibrate was given twice daily in a dose of 10 to 20 mg/kg/day. The mean plasma total cholesterol concentration on bezafibrate was 22% lower than during the period on placebo and there was a moderate rise in high density lipoprotein cholesterol. Bezafibrate may be a useful adjunct to treatment in these children.
6
The Lipid Research Clinics Coronary Primary Prevention Trial Results
JAMA · 1984 · 2.8K citations
The Metabolic Basis of Inherited Disease.
Annals of Internal Medicine · 1983 · 2.7K citations
Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol.
J V Leonard, A G Whitelaw, O. Wolff et al. · BMJ · 1977 · 62 citations · Full text
Life Sciences, Genetics, Pediatrics +14
The pharmacology and toxicology of a new tropane alkaloid derivative.
West Rj, Fosbrooke As, Lloyd Jk · PubMed · 1975 · 57 citations · Full text